Clinical Pharmacology and Resistance to Dihydrofolate Reductase Inhibitors

This publication has 67 references indexed in Scilit:

• A Binding Site for SH3 Domains Targets Dynamin to Coated Pits
  Published by Elsevier ,1996
• Molecular Cloning of the Human Placental Folate Transporter
  Biochemical and Biophysical Research Communications, 1995
• Trimetrexate: A Critical Appraisal of the Phase II Clinical Trial Experience: Evidence of Drug Discovery-Clinical Development Disjunction
  Cancer Investigation, 1994
• Potocytosis: Sequestration and Transport of Small Molecules by Caveolae
  Science, 1992
• Phase II Trial of Trimetrexate in the Treatment of Recurrent Childhood Acute Lymphoblastic Leukemia: A pediatric Oncology Group Study
  JNCI Journal of the National Cancer Institute, 1990
• Trimetrexate for the Treatment ofPneumocystis cariniiPneumonia in Patients with the Acquired Immunodeficiency Syndrome
  New England Journal of Medicine, 1987
• Amplification and organization of dihydrofolate reductase genes in a human leukemic cell line, K-562, resistant to methotrexate
  Biochemistry, 1983
• The Pharmacology and Clinical Use of Methotrexate
  New England Journal of Medicine, 1983
• The protein binding of methotrexate by the serum of normal subjects
  European Journal of Clinical Pharmacology, 1979
• Temporary Remissions in Acute Leukemia in Children Produced by Folic Acid Antagonist, 4-Aminopteroyl-Glutamic Acid (Aminopterin)
  New England Journal of Medicine, 1948